Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Targeted Oncology|September 24, 2022
Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2- Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 StudyMichelino De Laurentiis, Roberta Caputo, Manuelita Mazza, et al.
European Journal of Medicinal Chemistry|August 28, 2015
Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeuticsGiovanna Sociali, Lauretta Galeno, Marco Daniele Parenti, et al.
The Journal of Biological Chemistry|October 22, 2014
Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activityDebora Soncini, Irene Caffa, Gabriele Zoppoli, et al.
Plos One|August 6, 2011
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cellsMichele Cea, Debora Soncini, Floriana Fruscione, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2016
Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation StatusMichele Cea, Antonia Cagnetta, Chirag Acharya, et al.
Blood|December 18, 2015
Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cellsMichele Cea, Antonia Cagnetta, Sophia Adamia, et al.
Journal for Immunotherapy of Cancer|May 8, 2020
Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune responseJessica Roelands, Wouter Hendrickx, Gabriele Zoppoli, et al.
Journal of the National Cancer Institute|May 5, 2022
Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted TherapyMatteo Lambertini, Shona Fielding, Sibylle Loibl, et al.
Cancer Treatment and Research Communications|September 1, 2024
Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patientsFrancesca Parisi, Giuseppa De Luca, Manuela Mosconi, et al.
Cell Reports|June 21, 2025
Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitorsFrancesco Ravera, Martina Dameri, Isabella Lombardo, et al.
Pageof 13